Sai Life Sciences' IPO saw an 84% subscription rate on its first day. Institutional investors showed strong interest. The IPO aims to raise Rs 3,042 crore. The company plans to use the funds for debt repayment. Analysts are cautious due to the IPO's high valuation. The offer includes a large OFS component. The IPO closes on December 13.
